Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 May 28;10(5):174-178.
doi: 10.1016/j.aace.2024.05.002. eCollection 2024 Sep-Oct.

Noonan Syndrome and Celiac Disease in an Adolescent With Short Stature and Delayed Puberty

Affiliations
Case Reports

Noonan Syndrome and Celiac Disease in an Adolescent With Short Stature and Delayed Puberty

Justin Lee et al. AACE Clin Case Rep. .

Abstract

Background/objective: We present an adolescent male with Noonan syndrome (NS) and celiac disease (CD) who attained normal adult height with growth hormone (GH) treatment and gluten-free diet (GFD).

Case report: A 15 ½ year old healthy male presented with short stature and delayed puberty. His mother and maternal grandmother were short with heights 142.2 cm and 147.3 cm, respectively. Examination showed bilateral epicanthal folds and down slanting eyes like his mother, fifth finger clinodactyly, height 147.5 cm (<1%; standard deviation score, -2.96), growth velocity 2.5 cm/y, weight 48.2 kg (11%; standard deviation score, -1.24), Tanner 2 pubic hair and Tanner 1 genitalia. Midparental target height was 169.1 cm. He had normal screening studies for GH deficiency and thyroid disorders, prepubertal gonadotropins and testosterone levels, and normal total immunoglobulin A, and elevated antitissue transglutaminase immunoglobulin A 134.7units/mL (0-20). Bone age was 13 years. Genetic evaluation revealed heterozygous missense variant of BRAF gene in him and his mother confirming a diagnosis of NS. He was diagnosed with CD by intestinal biopsy. Patient was started on GH therapy and a GFD with subsequent improvement in growth velocit (6.8-12.3 cm/y) and advancement of puberty. The patient stopped GH therapy at 17 ½ years with a height 165.9 cm.

Discussion: Coexistence of NS caused by BRAF missense variant and CD has not been previously reported. Our patient attained normal adult height with GH therapy and GFD.

Conclusion: NS and CD can co-occur and addressing both these disorders can help patients attain normal height potential.

Keywords: BRAF mutation; Noonan syndrome; celiac disease; gluten-free diet; growth hormone.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose. There is no funding support for this study.

Figures

Fig. 1
Fig. 1
Growth chart of the patient based on Centers for Disease Control growth chart for boys 2 to 20 years. BMI = body mass index; GH = growth hormone.
Fig. 2
Fig. 2
Growth chart of the patient based on growth chart for boys with Noonan syndrome. GH = growth hormone.

References

    1. Noonan J.A. Noonan syndrome and related disorders: alterations in growth and puberty. Rev Endocr Metab Disord. 2006;7(4):251–255. - PMC - PubMed
    1. Rauen K.A. The RASopathies. Annu Rev Genomics Hum Genet. 2013;14:355–369. - PMC - PubMed
    1. Alanay Y., Balcı S., Ozen S. Noonan syndrome and systemic lupus erythematosus: presentation in childhood. Clin Dysmorphol. 2004;13(3):161–163. - PubMed
    1. Uehara T., Hosogaya N., Matsuo N., Kosaki K. Systemic lupus erythematosus in a patient with Noonan syndrome-like disorder with loose anagen hair 1: more than a chance association. Am J Med Genet. 2018;176(7):1662–1666. - PubMed
    1. Lisbona M.P., Moreno M., Orellana C., Gratacos J., Larrosa M. Noonan syndrome associated with systemic lupus erythematosus. Lupus. 2009;18(3):267–269. - PubMed

Publication types

LinkOut - more resources